Home > Blog > Ind success strategy building a high quality ind from scratch with strategic gap analysis

1 min read

IND Success Strategy: Building a High-Quality IND from Scratch with Strategic Gap Analysis

Clinical Trial Regulations Strategic Consulting

Learn how our regulatory affairs team was able to work with a sponsor to build a complete, FDA-compliant IND from scratch. Our collaborative efforts led to successful IND submission and initiation of clinical trials with confidence, preventing potential delays and clinical holds.

A sponsor without internal regulatory expertise needed to create and submit an Investigational New Drug (IND) application and turned to Veristat for comprehensive support. They required in-depth regulatory guidance to ensure a compliant IND submission and smooth development process moving forward, knowing that missing or incomplete documentation could cause costly delays.

👉 In this case study, learn how our regulatory team was able to work with the sponsor to solve challenges across numerous areas including:

  • Strategic gap analysis

  • IND planning and management

  • Medical writing coordination

  • Document authoring

  • eCTD publishing

  • FDA submission support

Download our complete case study "IND Success Strategy: Building a High-Quality IND from Scratch with Strategic Gap Analysis"
DOWNLOAD

2 min read

SCDM ANNUAL CONFERENCE 2026

Jul 24, 2026  Veristat Events

Meet Veristat at the SCDM Annual ConferenceSeptember 14–17, 2026 – Raleigh, North Carolina

Advancing Clinical Data...

2 min read

Connect with Veristat at Bio International Convention 2026

Jun 15, 2026  Veristat Events

June 22-25, 2026 – San Diego, CA

🌎 Bringing the Global Biopharma Community Together

We’re delighted to be attending...